GLP-1 Near Me in New York — Semaglutide $99/Mo, Tirzepatide $125/Mo | Trimi
Stop searching for GLP-1 clinics near you in New York. Trimi delivers compounded semaglutide and tirzepatide directly to your New York address in 2–3 business days — no clinic visits, no insurance required.
More on GLP-1 by Location
GLP-1 Weight Loss Treatment Available in New York
If you are searching for GLP-1 medication near you in New York, you have likely discovered that local weight loss clinics charge $300–800 per month and brand-name options like Wegovy and Zepbound cost $1,000–$1,400 without insurance. For many New York residents, these prices put effective weight loss treatment out of reach.
Trimi eliminates the need to find a GLP-1 clinic near you in New York. Through telehealth, you can access compounded semaglutide for $99/month or compounded tirzepatide for $125/month — delivered directly to any New York address. No clinic visit, no insurance, no prior authorization required.
New York GLP-1 Access Snapshot
Population: ~8.3 million city / ~20 million metro. Local clinic cost: $300–800/mo. Brand Wegovy/Zepbound: $1,000–$1,400/mo. Trimi telehealth: $99/mo semaglutide, $125/mo tirzepatide. Ships to any New York address.
Learn more about how telehealth prescribing works. You can also explore Ozempic vs. Wegovy or read our GLP-1 beginner guide.
New York GLP-1 Pricing: Trimi vs Local Providers & Pharmacies
| Option | Monthly Cost | In-Person Visit | Insurance Required |
|---|---|---|---|
| New York Weight Loss Clinic (avg) | $300–$800 | Yes | Sometimes |
| New York Pharmacy (brand Wegovy/Zepbound) | $1,000–$1,400 | Yes | Recommended |
| Trimi Telehealth (compounded) | $99/mo (sema) / $125/mo (tirz) | No | No |
Not sure which GLP-1 medication is right for you? Read our semaglutide vs. tirzepatide comparison.
How It Works: 3 Steps to Get GLP-1 Medication in New York
Step 1: Online Health Intake
Complete a health questionnaire covering your medical history, medications, BMI, and weight loss goals — from anywhere in New York.
Step 2: Provider Review & Prescription
A licensed New York provider evaluates your submission, confirms GLP-1 candidacy, and prescribes either semaglutide or tirzepatide based on your health profile.
Step 3: Delivered to Your New York Door
Temperature-controlled packaging arrives at your New York address within 3–5 business days. Monthly refills ship automatically.
Check our GLP-1 candidacy guide to see if you qualify for treatment.
GLP-1 Medications Available for New York Residents
Compounded Semaglutide
$99/month
- Same active ingredient as Wegovy
- GLP-1 receptor agonist
- ~15% average weight loss at 68 weeks
- No insurance required
Compounded Tirzepatide
$125/month
- Same active ingredient as Mounjaro/Zepbound
- Dual GLP-1/GIP receptor agonist
- ~22% average weight loss at 72 weeks
- No insurance required
Learn about compounded medication safety, read our first month guide, and see the GLP-1 weight loss timeline.
Why New York Residents Choose Trimi Over Local GLP-1 Clinics
Traditional weight loss clinics in New York require in-person visits, often have long wait times, and charge $300–800 per month. Trimi's telehealth model eliminates these barriers. Whether you're in Brooklyn, Manhattan, or Queens or anywhere in the greater New York metro, your GLP-1 medication ships directly to your door for a flat monthly rate.
Explore our guide to managing GLP-1 side effects, learn about the telehealth process, or check out diet tips while on GLP-1 medications.
Ready to Start GLP-1 Treatment in New York?
Stop searching for GLP-1 clinics near you. Get compounded semaglutide ($99/mo) or tirzepatide ($125/mo) delivered to any New York address.
Get Started TodayFrequently Asked Questions: GLP-1 Near Me in New York
Where can I get GLP-1 medication near me in New York?
Trimi delivers GLP-1 medications directly to your New York address via telehealth. There is no need to search for a clinic near you — complete an online health intake, get evaluated by a licensed provider, and receive compounded semaglutide ($99/mo) or tirzepatide ($125/mo) shipped to your door.
How much do GLP-1 medications cost in New York?
Local New York weight loss clinics typically charge $300–800 per month for GLP-1 programs. Brand-name Wegovy or Zepbound cost $1,000–$1,400/month without insurance. Trimi offers compounded semaglutide for $99/month and tirzepatide for $125/month — shipped directly to your New York address.
Do I need a prescription for GLP-1 medication in New York?
Yes, GLP-1 medications like semaglutide and tirzepatide require a prescription from a licensed healthcare provider. Trimi's telehealth platform connects you with a licensed New York provider who evaluates your health history and prescribes the appropriate medication — all online.
How fast is GLP-1 shipping to New York?
Most New York residents receive their GLP-1 medication within 3–5 business days after prescription approval. Medication ships directly to your address — whether you're in Brooklyn, Manhattan, or Queens.
What is the difference between semaglutide and tirzepatide?
Semaglutide (the active ingredient in Wegovy) targets GLP-1 receptors and produces approximately 15% body weight loss at 68 weeks. Tirzepatide (Mounjaro/Zepbound) targets both GLP-1 and GIP receptors, producing approximately 22% weight loss at 72 weeks. Trimi offers both options for New York residents.
Is telehealth prescribing for GLP-1 medications legal in New York?
Yes. New York law permits licensed providers to conduct telehealth evaluations and prescribe medications including GLP-1 agonists. Trimi connects New York residents with licensed providers who manage evaluation, prescribing, and ongoing care entirely online.
Can I switch between semaglutide and tirzepatide with Trimi in New York?
Yes. If you start with one medication and want to explore the other, your Trimi provider can evaluate whether switching is appropriate for your health profile. Many New York patients start with semaglutide ($99/mo) and later transition to tirzepatide ($125/mo) for enhanced results.
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. Semaglutide and tirzepatide are prescription medications requiring evaluation by a licensed healthcare provider. Individual results vary. Common side effects include nausea, vomiting, diarrhea, and constipation. Not appropriate for individuals with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- New York City Public Health Department. Community Health Assessment 2023.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).